Senti Biosciences Holdings, Inc.
SNTI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001854270
No open-market purchases or sales by Senti Biosciences Holdings, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $6.37M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Senti Biosciences Holdings, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −2 vs. Q4 2022
- Shares held
- 12.6M
- +206.9K (+1.7%) vs. Q4 2022
- Total value
- $14.3M
- −$2.32M (−14.0%) vs. Q4 2022
- New holders
- 2
- 4 more added
- Sold out
- 4
- 4 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNTI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $6.37M |
| Q1 2026 | 16 | $4.58M |
| Q4 2025 | 15 | $5.84M |
| Q3 2025 | 16 | $8.27M |
| Q2 2025 | 15 | $14.2M |
| Q1 2025 | 16 | $19.9M |
| Q4 2024 | 16 | $3.23M |
| Q3 2024 | 14 | $2.41M |
| Q2 2024 | 20 | $2.17M |
| Q1 2024 | 27 | $4.15M |
| Q4 2023 | 25 | $7.56M |
| Q3 2023 | 26 | $5.02M |
| Q2 2023 | 28 | $7.64M |
| Q1 2023 | 24 | $14.3M |
| Q4 2022 | 26 | $16.6M |
| Q3 2022 | 23 | $27.8M |
| Q2 2022 | 20 | $22.1M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Senti Biosciences Holdings, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 133 | $157 | 0.00% | +2+1.5% | Added |
| Wolverine Asset Management LLC | 800 | $944 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 2,000 | $2.36K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,398 | $6.37K | 0.00% | −419−7.2% | Reduced |
| Bank of New York Mellon Corp | 12,369 | $14.6K | 0.00% | 00.0% | Unchanged |
| CIBC Asset Management Inc | 13,203 | $15.6K | 0.00% | +13,203 | New |
| Citigroup Inc | 14,472 | $17.1K | 0.00% | +14,472 | New |
| Allen Operations LLC | 21,443 | $25.3K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 36,848 | $43.5K | 0.00% | +22,552+157.8% | Added |
| State Street Corp | 39,100 | $46.1K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 40,052 | $47.3K | 0.00% | 00.0% | Unchanged |
| Artal Group S.A. | 55,555 | $66.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 95,000 | $112.1K | 0.00% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 117,871 | $139.1K | 0.00% | 00.0% | Unchanged |
| TD Asset Management Inc | 118,292 | $139.6K | 0.00% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 195,792 | $231.0K | 0.15% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 200,187 | $236.2K | 0.00% | 00.0% | Unchanged |
| Hongkou Capital LP | 210,883 | $248.8K | 0.82% | +59,208+39.0% | Added |
| Morgan Stanley | 249,858 | $294.8K | 0.00% | −2,326−0.9% | Reduced |
| Vanguard Group Inc | 515,431 | $608.2K | 0.00% | 00.0% | Unchanged |
| Intel Corp | 595,665 | $702.9K | 0.35% | 00.0% | Unchanged |
| ARK Investment Management LLCSuperinvestorARK Invest | 1,901,467 | $2.24M | 0.02% | −24,360−1.3% | Reduced |
| Price T Rowe Associates Inc | 3,467,866 | $4.09M | 0.00% | −86,151−2.4% | Reduced |
| NEA Management Company, LLC | 4,700,385 | $4.92M | 0.34% | +274,234+6.2% | Added |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −23,082−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −22,694−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −17,700−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −20−100.0% | Sold out |